These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 816644)

  • 1. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic properties of ethosuximide in monkeys. II. Chronic intravenous and oral administration.
    Patel IH; Levy RH
    Epilepsia; 1975 Dec; 16(5):717-30. PubMed ID: 816645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ethosuximide in the dog.
    el Sayed MA; Löscher W; Frey HH
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):180-92. PubMed ID: 708147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of progabide, a new gamma-aminobutyric acid-mimetic drug, in rhesus monkey.
    Johno I; Ludwick BT; Levy RH
    J Pharm Sci; 1982 Jun; 71(6):633-6. PubMed ID: 7097524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
    Tang-Liu DD; Richman JB; Lin P; Selim S
    Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Distribution, absorption and elimination of radioactivity following oral and intravenous application of 2'-14C-labelled cyproterone acetate to rhesus monkeys (author's transl)].
    Schulz V
    Arzneimittelforschung; 1976 Apr; 26(4):544-6. PubMed ID: 821492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethosuximide disposition kinetics in rats.
    Bachmann K; Jahn D; Yang C; Schwartz J
    Xenobiotica; 1988 Apr; 18(4):373-80. PubMed ID: 3400266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol kinetics after oral and intravenous doses.
    Holley FO; Magliozzi JR; Stanski DR; Lombrozo L; Hollister LE
    Clin Pharmacol Ther; 1983 Apr; 33(4):477-84. PubMed ID: 6831826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of carbamazepine in monkeys following intravenous and oral administration.
    Levy RH; Lockard JS; Green JR; Friel P; Martis L
    J Pharm Sci; 1975 Feb; 64(2):302-7. PubMed ID: 1127587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
    Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of dose dependent kinetics of methyl salicylate-2-O-β-D-lactoside in rhesus monkeys after oral administration.
    He Y; Yan Y; Zhang T; Ma Y; Zhang W; Wu P; Song J; Wang S; Du G
    J Ethnopharmacol; 2015 Apr; 164():293-300. PubMed ID: 25571846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE; Krieter PA
    Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicokinetics of deltamethrin and its 4'-HO-metabolite in the rat.
    Anadón A; Martinez-Larrañaga MR; Fernandez-Cruz ML; Diaz MJ; Fernandez MC; Martinez MA
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):8-16. PubMed ID: 8917670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition.
    Zhang X; Nieforth K; Lang JM; Rouzier-Panis R; Reynes J; Dorr A; Kolis S; Stiles MR; Kinchelow T; Patel IH
    Clin Pharmacol Ther; 2002 Jul; 72(1):10-9. PubMed ID: 12152000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and absolute bioavailability of atenolol.
    Mason WD; Winer N; Kochak G; Cohen I; Bell R
    Clin Pharmacol Ther; 1979 Apr; 25(4):408-15. PubMed ID: 428185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
    Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
    Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
    Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK
    Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.